Mark H. Wenink

1.7k total citations
41 papers, 958 citations indexed

About

Mark H. Wenink is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, Mark H. Wenink has authored 41 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 22 papers in Rheumatology and 9 papers in Hematology. Recurrent topics in Mark H. Wenink's work include Spondyloarthritis Studies and Treatments (15 papers), Psoriasis: Treatment and Pathogenesis (14 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). Mark H. Wenink is often cited by papers focused on Spondyloarthritis Studies and Treatments (15 papers), Psoriasis: Treatment and Pathogenesis (14 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). Mark H. Wenink collaborates with scholars based in Netherlands, United States and United Kingdom. Mark H. Wenink's co-authors include Timothy R. D. J. Radstake, Kim C. M. Santegoets, Wim B. van den Berg, Piet L. C. M. van Riel, Emmerik F A Leijten, Marianne Boes, Lenny van Bon, Tessa S. van Kempen, Timothy R. D. J. Radstake and F.H.J. van den Hoogen and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and FEBS Letters.

In The Last Decade

Mark H. Wenink

40 papers receiving 943 citations

Peers

Countries citing papers authored by Mark H. Wenink

Since Specialization

Citations

This map shows the geographic impact of Mark H. Wenink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Wenink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Wenink more than expected).

Fields of papers citing papers by Mark H. Wenink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Wenink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Wenink. The network helps show where Mark H. Wenink may publish in the future.

Co-authorship network of co-authors of Mark H. Wenink

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Wenink. A scholar is included among the top collaborators of Mark H. Wenink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Wenink. Mark H. Wenink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort 2022 ·Acta Dermato Venereologica ·(unknown), (unknown), Mark H. Wenink, Marcel C. Pasch, F.H.J. van den Hoogen, J. M. P. A. van den Reek, E.M.G.J. de Jong	7
2	Determinants of work and social participation in patients with psoriatic arthritis in the Netherlands: an observational study 2022 ·BMC Rheumatology ·(unknown), (unknown), Mark H. Wenink, Johanna E Vriezekolk	3
3	Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial 2022 ·The Lancet Rheumatology ·(unknown), Johanna E Vriezekolk, (unknown), (unknown), Nathan den Broeder, E.M.G.J. de Jong, Alfons A den Broeder, F.H.J. van den Hoogen, Philip Helliwell, Mark H. Wenink	18
4	Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): Protocol for a Longitudinal Observational Study 2021 ·JMIR Research Protocols ·(unknown), J. M. P. A. van den Reek, Hans Groenewoud, Marcel C. Pasch, F.H.J. van den Hoogen, Mark H. Wenink, E.M.G.J. de Jong	2
5	Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review 2021 ·Arthritis Research & Therapy ·(unknown), (unknown), Mark H. Wenink, Hans J. P. M. Koenen, F.H.J. van den Hoogen, E.M.G.J. de Jong, J.M.P.A. van den Reek, Johanna E Vriezekolk	24
6	Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritis. 2020 ·PubMed ·(unknown), Lucas L. van den Hoogen, Jan Meeldijk, (unknown), (unknown), Marianne Boes, Mark H. Wenink, C. Erik Hack, Timothy R. D. J. Radstake, Joël A. G. van Roon, Niels Bovenschen	5
7	Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial 2020 ·Trials ·(unknown), (unknown), Nathan den Broeder, Mark H. Wenink, Aatke van der Maas, E. Mahler, (unknown), Désirée van der Heijde, F.H.J. van den Hoogen, Lise M Verhoef, Alfons A den Broeder	11
8	<p>Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment</p> 2019 ·Patient Preference and Adherence ·(unknown), Elke Mathijssen, Marcia Vervloet, Annelies Boonen, (unknown), Annelieke Pasma, Harald E. Vonkeman, Mark H. Wenink, Bart J. F. van den Bemt, Liset van Dijk	17
9	Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity 2018 ·Frontiers in Immunology ·Onno J. Arntz, Bartijn C. H. Pieters, Rogier M. Thurlings, Mark H. Wenink, Peter L. E. M. van Lent, Marije I. Koenders, F.H.J. van den Hoogen, P.M. van der Kraan, Fons A. J. van de Loo	33
10	Perception of self: distinguishing autoimmunity from autoinflammation 2015 ·Nature Reviews Rheumatology ·Tessa S. van Kempen, Mark H. Wenink, Emmerik F A Leijten, Timothy R. D. J. Radstake, Marianne Boes	83
11	Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid 2015 ·Arthritis & Rheumatology ·Emmerik F A Leijten, Tessa S. van Kempen, Marianne Boes, (unknown), DirkJan Hijnen, Sarita A. Y. Hartgring, Joël A. G. van Roon, Mark H. Wenink, Timothy R. D. J. Radstake	98
12	Fc Gamma Receptor IIb on GM-CSF Macrophages Controls Immune Complex Mediated Inhibition of Inflammatory Signals 2014 ·PLoS ONE ·Kim C. M. Santegoets, Mark H. Wenink, Wim B. van den Berg, Timothy R. D. J. Radstake	15
13	Soluble Immune Complexes Shift the TLR-Induced Cytokine Production of Distinct Polarized Human Macrophage Subsets towards IL-10 2012 ·PLoS ONE ·Carmen A. Ambarus, Kim C. M. Santegoets, Lenny van Bon, Mark H. Wenink, Paul P. Tak, Timothy R. D. J. Radstake, Dominique Baeten	51
14	Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulation 2011 ·Annals of the Rheumatic Diseases ·Mark H. Wenink, Kim C. M. Santegoets, Andrew M. Platt, Wim B. van den Berg, Piet L. C. M. van Riel, Paul Garside, Timothy R. D. J. Radstake, Iain B. McInnes	27
15	Toll‐like receptors in rheumatic diseases: Are we paying a high price for our defense against bugs? 2011 ·FEBS Letters ·Kim C. M. Santegoets, (unknown), Wim B. van den Berg, Mark H. Wenink, Timothy R. D. J. Radstake	32
16	Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis 2011 ·Arthritis & Rheumatism ·Mark H. Wenink, Kim C. M. Santegoets, John Butcher, Lenny van Bon, (unknown), Wim B. van den Berg, Piet L. C. M. van Riel, Iain B. McInnes, Timothy R. D. J. Radstake	23
17	TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop 2009 ·The Journal of Immunology ·Mark H. Wenink, Kim C. M. Santegoets, (unknown), Lenny van Bon, Shahla Abdollahi‐Roodsaz, Călin D. Popa, Richard Huijbens, (unknown), Erik Lubberts, Piet L. C. M. van Riel, Wim B. van den Berg, Timothy R. D. J. Radstake	52
18	Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression 2009 ·PLoS ONE ·Timothy R. D. J. Radstake, Lenny van Bon, Jasper Broen, Mark H. Wenink, Kim C. M. Santegoets, Yanhui Deng, (unknown), Robert W. Simms, William W. Cruikshank, Robert Lafyatis	131
19	Dendritic Cells and their Potential Implication in Pathology and Treatment of Rheumatoid Arthritis 2008 ·Handbook of experimental pharmacology ·Mark H. Wenink, Wanda G. H. Han, René E. M. Toes, Timothy R. D. J. Radstake	25
20	The functional variant of the inhibitory Fcγ receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis 2006 ·Arthritis & Rheumatism ·Timothy R. D. J. Radstake, Barbara Franke, Mark H. Wenink, Karin C. Nabbe, Marieke J. H. Coenen, Paco M J Welsing, Ezio Bonvini, Scott Koenig, Wim B. van den Berg, Pilar Barrera, Piet L. C. M. van Riel	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact